(Q36846752)

English

The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.

scientific article published on January 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%. (English)

1 reference

Europe PubMed Central

16 August 2017

1 reference

based on heuristic

inferred from title

author name string

Diestelhorst M

1

1 reference

Europe PubMed Central

16 August 2017

Roters S

2

1 reference

Europe PubMed Central

16 August 2017

Krieglstein GK

3

1 reference

Europe PubMed Central

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1997

1 reference

Europe PubMed Central

16 August 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

16 August 2017

235

1 reference

Europe PubMed Central

16 August 2017

1

1 reference

Europe PubMed Central

16 August 2017

20-26

1 reference

Europe PubMed Central

16 August 2017

https://scigraph.springernature.com/pub.10.1007/bf01007833

0 references

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF01007833

21 January 2018

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin-induced iridial pigmentation in primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Electron microscopy and immunohistochemical studies of the intraocular pressure lowering effect of prostaglandin F2 alpha]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2 alpha-isopropyl ester analogues for glaucoma treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of timolol on aqueous humor protein concentration in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of prostaglandin F2 alpha in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorophotometric studies of prostaglandin effects on the human eye: the lack of association of reduced intraocular pressure with altered flow or barrier function

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9034838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01007833

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36846752&oldid=1626365634"